Current guidelines recommend lowering blood pressure (BP) in patients with chronic kidney disease and hypertension. However, a new study suggests that achieving ideal systolic BP targets at the expense of low diastolic BP <70 mmHg is not advantageous for outcomes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Kovesdy, C. P. et al. Blood pressure and mortality in U. S. veterans with chronic kidney disease: a cohort study. Ann. Intern. Med. 159, 233–242 (2013).
Peterson, J. C. et al. Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann. Intern. Med. 123, 754–762 (1995).
Appel, L. J. et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363, 918–929 (2010).
Ruggenenti, P. et al. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 365, 939–946 (2005).
Wheeler, D. C. & Becker, G. J. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease? Kidney Int. 83, 377–383 (2013).
Mancia, G. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013).
[No authors listed]. Summary of revisions for the 2013 clinical practice recommendations. Diabetes Care 36 (Suppl. 1), S3 (2013).
Hansson, L. et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351, 1755–1762 (1998).
Panjrath, G. S., Chaudhari, S. & Messerli, F. H. The j-point phenomenon in aggressive therapy of hypertension: new insights. Curr. Atheroscler. Rep. 14, 124–129 (2012).
Peralta, C. A. et al. Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch. Intern. Med. 172, 41–47 (2012).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Bakris, G. Optimal blood pressure for kidney disease—lower is not better. Nat Rev Nephrol 9, 634–635 (2013). https://doi.org/10.1038/nrneph.2013.206
Published:
Issue date:
DOI: https://doi.org/10.1038/nrneph.2013.206
This article is cited by
-
Update on Blood Pressure Goals in Diabetes Mellitus
Current Cardiology Reports (2015)
